APA

Howells L. M., Berry D. P., Elliott P. J., Jacobson E. W., Hoffmann E., Hegarty B., Brown K., Steward W. P. & Gescher A. J. (20120105). Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. : Cancer prevention research (Philadelphia, Pa.).

Chicago

Howells Lynne M, Berry D P, Elliott P J, Jacobson E W, Hoffmann E, Hegarty B, Brown K, Steward W P and Gescher A J. 20120105. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. : Cancer prevention research (Philadelphia, Pa.).

Harvard

Howells L. M., Berry D. P., Elliott P. J., Jacobson E. W., Hoffmann E., Hegarty B., Brown K., Steward W. P. and Gescher A. J. (20120105). Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. : Cancer prevention research (Philadelphia, Pa.).

MLA

Howells Lynne M, Berry D P, Elliott P J, Jacobson E W, Hoffmann E, Hegarty B, Brown K, Steward W P and Gescher A J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. : Cancer prevention research (Philadelphia, Pa.). 20120105.